Stocks making the biggest moves after hours: AeroVironment, American Eagle, Cooper Companies & more

Extended trading was led lower by Cooper Companies, down roughly 14% after issuing Q4 guidance of $1.057B-$1.080B in revenue and $1.05-$1.09 in adjusted EPS, below consensus of $1.11B and $1.19. American Eagle fell 10% after comparable sales declined 1% versus a 0.6% expected decline and its $110M-$115M operating-income outlook missed the $124.3M consensus; Navan dropped 12% despite a narrow EPS beat. Offsetting gains were limited, with AeroVironment up 2% after reporting $0.59 adjusted EPS and $480M revenue, well above estimates of $0.25 and $456M, while Enbridge fell 2% following its $2.55B acquisition of Tallgrass Energy's crude-transportation business.

Analysis

The most actionable read-through is a widening quality dispersion rather than a uniform earnings-risk signal. AVAV’s modest reaction despite a material beat implies investors are demanding evidence that growth converts into durable funded backlog and higher-margin autonomous-systems mix; confirmation could support a 1-3 month estimate-revision cycle, while a weak bookings or cash-conversion disclosure would cap upside. Defense peers with less program concentration, including KTOS and NOC, are potential secondary beneficiaries if the result signals sustained unmanned-system procurement rather than a company-specific delivery cadence.

COO and AEO face more consequential multiple risk because forward expectations—not the reported quarter—are resetting. For COO, lower utilization of fixed manufacturing and adverse product/geographic mix could turn a modest revenue gap into disproportionate EPS pressure over the next two quarters; watch whether ALGN, HSIC and XRAY report similar elective-care softness to distinguish an industry demand issue from execution. For AEO, the relevant downside is promotional intensity and inventory markdown risk: if gross-margin commentary weakens alongside the sales miss, consensus revisions may lag the shares and create another 1-3 months of underperformance.

ENB’s acquisition should be evaluated through financing terms and return on invested capital, not initial strategic messaging. If debt-funded, incremental leverage and a higher-rate-for-longer backdrop can delay accretion and widen the valuation discount versus more self-funded pipeline peers; conversely, contracted cash flows and an asset sale or equity issuance would reduce that risk. NAVN and WLTH appear to have delivered too little operating surprise to overcome valuation and execution concerns, making them poor dip-buy candidates absent evidence of accelerating net revenue retention or asset growth.

Contrarian view: the sharpest post-market declines may be directionally correct but not equally investable. COO’s reset is more likely to persist if it reflects end-market softness, whereas AEO can stabilize quickly if inventory is clean and margin preservation remains intact; the next channel-check and monthly retail data matter more than a single quarterly comp.

Key Decisions for Investors

• Maintain a 1-3 month short bias in COO, preferably via a long ALGN / short COO pair to isolate Cooper-specific guidance risk. Reassess if COO restores next-quarter EPS guidance above consensus or if peer commentary confirms broad-based elective-care demand strength.
• Do not chase AVAV solely on the earnings beat. Set an alert to initiate a 3-6 month long only if funded backlog/bookings and free-cash-flow conversion confirm that the upside is not shipment timing; use KTOS as a lower-expectation alternative if the unmanned-defense spending theme broadens.
• Avoid averaging down in AEO before management provides inventory and gross-margin evidence. A tactical short is warranted only if post-earnings weakness persists and promotional activity rises; cover if inventory turns improve or operating-income guidance is reaffirmed after the holiday order cycle.
• Keep ENB at market weight pending acquisition financing and leverage disclosure. Prefer TRP or KMI for North American midstream exposure if ENB’s transaction pushes leverage higher without a clearly contracted EBITDA contribution; a narrowing relative valuation discount would falsify the concern.
• Treat NAVN and WLTH as watch items rather than longs: require evidence of accelerating recurring revenue/retention for NAVN and sustained asset-growth plus margin expansion for WLTH before underwriting multiple expansion.